Cargando…
GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice
It has been proved that interleukin-10-knockout (IL-10 KO) mice display the most similar characteristics to that of human Crohn's disease (CD). Docosahexaenoic acid (DHA) has well established beneficial effects on human and animal models health with potent anti-inflammatory effects with poorly...
Autores principales: | Zhao, Jie, Wang, Honggang, Shi, Peiliang, Wang, Wenbo, Sun, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352409/ https://www.ncbi.nlm.nih.gov/pubmed/28039475 http://dx.doi.org/10.18632/oncotarget.14210 |
Ejemplares similares
-
FFA4/GPR120: Pharmacology and Therapeutic Opportunities
por: Milligan, Graeme, et al.
Publicado: (2017) -
Regulation of Energy Homeostasis via GPR120
por: Ichimura, Atsuhiko, et al.
Publicado: (2014) -
GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome
por: Qin, Zhangjin, et al.
Publicado: (2022) -
Spontaneous colitis in IL‐10‐deficient mice was ameliorated via inhibiting glutaminase1
por: Li, Jing, et al.
Publicado: (2019) -
CD4(+)-mediated colitis in mice is independent of the GPR183 and GPR18 pathways
por: Dicker, Martina, et al.
Publicado: (2022)